# IMPROV (Improving the Radical Cure of Vivax Malaria)

> **NCT01814683** · NA · COMPLETED · sponsor: **University of Oxford** · enrollment: 2388 (actual)

## Conditions studied

- Uncomplicated Vivax Malaria

## Interventions

- **DRUG:** Primaquine
- **DRUG:** Primaquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01814683
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-02-28
- **Target enrollment:** 2388 (ACTUAL)
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01814683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01814683, "IMPROV (Improving the Radical Cure of Vivax Malaria)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01814683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*